KNUDSEN v. METLIFE GROUP, INC.

CourtDistrict Court, D. New Jersey
DecidedJuly 18, 2023
Docket2:23-cv-00426
StatusUnknown

This text of KNUDSEN v. METLIFE GROUP, INC. (KNUDSEN v. METLIFE GROUP, INC.) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
KNUDSEN v. METLIFE GROUP, INC., (D.N.J. 2023).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY

MARLA KNUDSEN and WILLIAM DUTRA, as the representatives of a class of similarly 2.4 situated persons, and on behalf of the MetLife Civ. No, 2:23-cv-00426 (WJM) Options & Choices Plan, Plaintiffs, OPINION

v. METLIFE GROUP, INC., Defendant.

In this action brought under the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), Defendant MetLife Group, Inc. (“MetLife” or “Defendant’’) moves to dismiss the Complaint filed by Plaintiffs Marla Knudsen and William Dutra _ (Plaintiffs’”), as the representatives of a class of similarly situated persons, and on behalf of the MetLife Options & Choices Plan (the “Plan”) pursuant to Fed. R. Civ. P. 12(b)(1) and (6). ECF No, 17. The Court decides the matter without oral argument. Fed. R. Civ. P. 78(b). For the reasons stated below, Defendant’s motion to dismiss for lack of Article II] standing is granted. Defendant’s motion to dismiss for failure to state a claim is denied as moot. L BACKGROUND Defendant sponsors the Plan to provide health and welfare benefits to its employees and employees of its affiliates and their families. Compl., { 9. Plaintiffs are former Plan participants who obtained medical and prescription drug coverage for themselves and their family members. /d. at {9 4, 13-14. To fund the Plan each year, Defendant applies a fixed formula to the projected overail cost of coverage for each medical benefit option and determines the specific contribution or premium for each employee, spouse, and dependent that is to be deducted each pay period. Ja. at (20. Defendant or its affiliates pay the balance ofthe cost of coverage. /d. During the last five years, Plan participants have paid on average about 30% of overall contributions to the Plan and MetLife has paid roughly 70%, which according to a Department of Labor form filed by the Plan was $234.5 million (72%) in 2021. Id. at § 21; Def.’s Mot. at 5, n.8. In addition to premiums, Plan participants must subsidize the Plan with out-of-pocket costs such as co-pays, co-insurance, and deductibles.

Id. at □ 22. Taking such costs into account, claims are paid from the trust funds held by the Plan. Jd. Throughout the relevant period, the Plan hired Express Scripts! as its pharmacy benefit manager (““PBM”). /d. at 22. PBMs commonly negotiate volume discounts and rebates with drug manufacturers. /d. at § 27. Between 2016 and 2021, the Plan earned approximately $65 million in drug rebates, which Plaintiffs allege Defendant wrongfully paid to itself for its own benefit. Jd. at J{ 3, 33. Had the drug rebates been properly allocated, Defendant “may have reduced co-pays and co-insurance for pharmaceutical benefits” and “may have distributed rebates to participants in proportion to their contributions to the Plan.” /d. at ¢ 36. Instead, Plaintiffs claim they were deprived of distributions or paid excessive amounts towards the cost of coverage, co-pays, and/or co- insurance, at 37. Plaintiffs filed suit on January 25, 2023 derivatively on behalf of the Plan and on behalf of “all participants and beneficiaries of the Plan since January 24, 2017, excluding” Plan fiduciaries. Jd. at § 43. Plaintiffs seek monetary and equitable relief under 29 U.S.C. § 1132(a)(2) and (a)(3) for the following violations of ERISA: establishment of trust and anti-inurement, 29 U.S.C. § 1103(a), (c) (Count I); prohibited transactions with a party-in- interest, 29 U.S.C. § 1106(a)(1)(D) (Count ID); prohibited transactions with a fiduciary, 29 U.S.C. § 1106(b)(1), (b)(3) (Count IID); breach of fiduciary standard of care, 29 U.S.C. § 1104(a)(1) (Count TV). Defendant now moves to dismiss pursuant to Fed. R. Civ. P. 12(b)(1) for lack of constitutional and statutory standing. Additionally, Defendant argues that dismissal is appropriate under Fed. R. Civ. P. 12(b)(6) for failure to state a claim under ERISA. Il. DISCUSSION A. Rule 12(b)(1) Federal Rule of Civil Procedure 12(b)(1) is the proper vehicle for challenging Article III standing, which is a component of subject matter jurisdiction. Fed. R. Civ. P. 12(b)(1); see Society Hill Towers Owners! Ass'n v. Rendell, 210 F.3d 168, 175 (d Cir. 2000). Article II of the Constitution limits the jurisdiction of federal courts to “Cases” and “Controversies,” U.S. Art. TI § 2. The burden of establishing jurisdiction rests with the party invoking federal court jurisdiction. Spokeo, Inc. v. Robins, 578 U.S. 330, 338 (2016), as revised (May 24, 2016); Animal Sci. Prod., Inc. v. China Minmetals Corp., 654 F.3d 462, 470 (3d Cir. 2011). Plaintiff must “clearly ... allege facts demonstrating” all three elements of constitutional standing: (1) an “injury in fact,” (2) that is “fairly traceable” to

' Plaintiffs do not challenge Defendant’s decision to hire Express Scripts. Pls.’ Opp’n Br. at 22, n. 6.

a defendant's conduct, and that (@) is likely to be redressed by favorable judicial intervention. Lujan y. Defs. of Wildlife, 504 U.S. 555, 561 (1992). In evaluating a facial challenge to jurisdiction pursuant to Rule 12(b)(1), the Court must accept as true all material allegations set forth in the complaint, and “must only consider the allegations of the complaint and documents referenced therein and attached thereto, in the light most favorable to the plaintiff.” Gould Elecs. Ine. v. United States, 220 F.3d 169, 176 (3d Cir. 2000); Baldwin v. Univ. of Pittsburgh Med. Ctr., 636 F.3d 69, 73 (3d Cir.2011) (“A dismissal for lack of statutory standing is effectively the same as a dismissal for failure to state a claim.”). Since Plaintiffs’ claims are based on a health benefits plan referenced in and integral to the Complaint, the Court may consider the Plan documents* without converting a motion to dismiss into a motion for summary judgment. See Univ. Spine Ctr. v. Anthem Blue Cross Blue Sheild [sic], No. 18-2912, 2018 WL 6567702, at *2 (D.N.J. Dec. 13, 2018). B. Article III Standing Analysis In challenging standing, Defendant does not dispute that monetary harm is a concrete injury. See Danvers Motor Co., Inc. v. Ford Motor Co,, 432 F.3d 286, 293 (3d Cir. 2005).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Massachusetts Mutual Life Insurance v. Russell
473 U.S. 134 (Supreme Court, 1985)
Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Varity Corp. v. Howe
516 U.S. 489 (Supreme Court, 1996)
Hughes Aircraft Co. v. Jacobson
525 U.S. 432 (Supreme Court, 1999)
Smith v. Medical Benefit Administrators Group, Inc.
639 F.3d 277 (Seventh Circuit, 2011)
Horvath v. Keystone Health Plan East, Inc.
333 F.3d 450 (Third Circuit, 2003)
Connie Edmonson v. Lincoln National Life Insuranc
725 F.3d 406 (Third Circuit, 2013)
Loren v. Blue Cross & Blue Shield of Mich.
505 F.3d 598 (Sixth Circuit, 2007)
Jeffrey Perelman v. Raymond Perelman
793 F.3d 368 (Third Circuit, 2015)
Danvers Motor Co. v. Ford Motor Co.
432 F.3d 286 (Third Circuit, 2005)
Hooven v. Exxon Mobil Corp.
465 F.3d 566 (Third Circuit, 2006)
Spokeo, Inc. v. Robins
578 U.S. 330 (Supreme Court, 2016)
James Thole v. U.S. Bank, National Assn.
873 F.3d 617 (Eighth Circuit, 2017)
Thole v. U. S. Bank N. A.
590 U.S. 538 (Supreme Court, 2020)

Cite This Page — Counsel Stack

Bluebook (online)
KNUDSEN v. METLIFE GROUP, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/knudsen-v-metlife-group-inc-njd-2023.